-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - Protocol for Identifying and Treating Children With Sepsis Syndrome in the Emergency Department
1
Protocol for Identifying and Treating Children with
Sepsis Syndrome in the Emergency Department
Section 1. Basic Measure Information
1.A. Measure Name
Protocol for Identifying and Treating Children with Sepsis Syn…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
January 01, 2024 - Evaluation of a wireless, portable, wearable multi-parameter vital signs monitor in hospitalized neurological
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/patientsafety/2017qdr-patsafchartbook.pdf
October 01, 2018 - Cardiology, Pulmonology, Neurology,
and Gastroenterology
Surgery: Colorectal Surgery, General Surgery, Neurological
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - Ann Neurol 2008) found no significant
impact of miglustat on neurological manifestations of Gaucher … Ann Neurol 2008) found no significant impact of miglustat, an
SRT, on neurological manifestations of
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q1Q3_IP_MaskedStats.PDF
October 01, 2014 - ACUTE MAJOR EYE INFECTIONS W CC/MCC 293 0.01
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 266 0.01
123: NEUROLOGICAL … ACUTE MAJOR EYE INFECTIONS W CC/MCC 293 0.01
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 266 0.01
123: NEUROLOGICAL
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_executive.pdf
March 01, 2016 - 1
Comparative Effectiveness Review
Number 177
Nonpharmacologic Interventions for Agitation
and Aggression in Dementia
Executive Summary
Background
Dementia and Agitation and
Aggression
The American Psychiatric Association’s
Diagnostic and Statistical Manual of
Mental Disorders, 5th Edition (DSM-5)
categoriz…
-
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 08: Functional Limitations and Disability
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - Symptoms from distant metastases may also be present
and include neurological defect or personality
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-interventions-maltreatment-child_executive.pdf
April 01, 2013 - psychiatric impairment
(e.g., severe depression, psychosis), and those affected
by a cognitive or neurological
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V22%20Definitions%20Manual.pdf
April 01, 2006 - 17
AGE 0 - 17 048 OTHER DISORDERS OF THE EYE AGE 0-17
044 044 ACUTE MAJOR EYE INFECTIONS
045 045 NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV25Public.pdf
June 01, 2009 - ACUTE MAJ EYE INF
122 121 ACUTE MAJ EYE INF
123 123 NEUROLOGICAL
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
June 01, 2014 - imaging activation in the bilateral middle occipital
cortex region of the brain, indicating a potential neurological
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
June 01, 2013 - treated with ACDF.8 At
24 months, 5.3% of the Mobi-C group and 5.7% of the ACDF showed deterioration in neurological
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_Weighted_V2.PDF
January 01, 2020 - INFECTIONS WITH CC/MCC 2,340 0.01%
122: ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC 1,265 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core_Weighted.PDF
January 01, 2022 - INFECTIONS WITH CC/MCC 3,535 0.01%
122: ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC 1,755 0.01%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core_Weighted.PDF
January 01, 2021 - INFECTIONS WITH CC/MCC 2,630 0.01%
122: ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC 1,305 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core_Weighted.PDF
January 01, 2018 - MAJOR EYE INFECTIONS W CC/MCC 2,960 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 1,735 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core.PDF
January 01, 2018 - MAJOR EYE INFECTIONS W CC/MCC 592 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 347 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_Weighted_V2.PDF
January 01, 2019 - MAJOR EYE INFECTIONS W CC/MCC 3,120 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 1,730 0.00%
123: NEUROLOGICAL
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-2005
July 12, 2005 - Childhood overweight and obesity’s health consequences include pulmonary, orthopedic, gastroenterological, neurological